None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male and Female Japanese subjects who participated clinical trial between December 2016 and May 2017, and who has following test data; - Demography: age, sex, height, weight and BMI. - General laboratory data and vital sign: BP (systolic and diastolic), pulse rate, laboratory data (WBC, Hb, Ht), Urine drug test. - Lung function tests: FVC, FEV1.0, FEV1/FVC - Other ( only for smoker): urine cotinine test (qualitative), exhaled Co and the number of cigarette smoked.
Exclusion criteria
Exclusion criteria: -
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Calculate basic statistics of smoker and non-smoker separately. Calculate basic statistics of lung function tests with/without bronchodilator (Beta 2 blocker) when the data is available. Conduct inter-group comparison of smoker / non-smoker or with / without bronchodilator. Compare acquired data with historical data. | — |
Secondary
| Measure | Time frame |
|---|---|
| Calculate basic statistics of sex, age, exhaled CO level, the number of cigarette smoke in smokers. | — |
Countries
Japan
Contacts
SOUSEIKAI Hakata Clinic Planning & Coordination Dept.